Cancer Prevention Webinars
Archived Webinars on Cancer Prevention
Title: Anal Cancer Prevention and Screening
Speakers:
Andrew Yu, MS, BSN, RN, ACRN
Public Health Advisor, HQ, IHS
Description: : Anal cancer is increasing significantly among some groups of people including those living with HIV, men who have sex with other men, women with cervical cancer, and people who are immunocompromised. Increased access to HPV vaccinations and updated anal cancer screening and treatment guidelines may help prevent new cases of anal cancer and decrease severity of disease and mortality.
Learning Objectives: At the end of the presentation, viewers will:
- Examine methods of anal cancer prevention including the use of HPV vaccination.
- Apply current anal cancer screening algorithm.
- Incorporate current anal cancer precursor treatment guidelines.
Title: Town Hall Panel: Breast Cancer Facts, Personal Cancer Journey, and Resources
Speakers:
Loretta Christensen, MD, MBA, MSJ, FACS
Chief Medical Officer, IHS
Melissa Buffalo, MS
Chief Executive Officer,American Indian Cancer Foundation
Description: American Indian and Alaska Native women are at risk for breast cancer. Please join us to learn how to reduce your risk, understand the importance of early detection, access available resources, recognize potential signs and symptoms, and hear a personal story of recovery.
Learning Objectives: At the conclusion of this webinar, the participants will be able to:
- Identify risk factors and signs and symptoms of breast cancer.
- Recognize the importance of early detection.
- Locate resources and information on breast cancer.
Title: Reigniting Colorectal Cancer Screening Efforts during COVID
Speakers:
Donald Haverkamp, MPH
Epidemiologist, CDC
Chelsea Kettering, DrPH, MPH
Epidemiologist, Health Promotion/Disease Prevention, Navajo Area Office, IHS
Farah Lazarre, FNP-C
Family Nurse Practitioner, Indian Family Health Clinic of Great Falls
Description: This presentation will focus on how two programs reignited colorectal cancer screenings by using alternative safe approaches to reduce anxieties that may prevent people from accessing screening programs. The speakers will share statistics, screening approaches, lessons learned, follow up, and how they adapted culturally appropriate materials to increase screening during COVID.
Learning Objectives: At the end of the presentation, the healthcare team will:
- Identify strategies offering at-home stool-based tests to reignite screening efforts.
- Implement team-based approaches that support colorectal cancer screenings.
- Locate cultural appropriate materials that can be adapted for sites to promote screening efforts.
Title: Understanding the Relationship Between Obesity and Cancer
October 21, 2021
Description: This presentation will discuss the prevalence of obesity in the U.S. and in various population subgroups, including American Indian/Alaska Native populations. The relationship of obesity to cancer incidence and outcomes; biological mechanisms that are thought to be responsible for the obesity-cancer relationship; and efforts by the National Cancer Institute (NCI) to better understand the obesity and cancer relationship and develop more effective interventions for obesity to prevent cancer and reduce its adverse outcomes.
Learning Objectives:
- Examine the relationship of obesity to cancer, including the types of cancer that are linked to obesity and apparent mechanisms linking obesity to cancer.
- Recognize obesity prevalence in the U.S. generally and in various population subgroups including American Indian/Alaska Natives.
- Summarize research and related activities being undertaken by the NCI in the area of obesity and cancer.
Speakers:
Susan Czajkowski, PhD
Chief Health Behaviors Research Branch, National Cancer Institute
Linda Nebeling, PhD, MPH, RD, FADA
Deputy Associate Director, DCCPS, NCI, NIH
Title: Cancer Prevention Interventions: Recommendation from the Community Preventive Service Task Force
October 19, 2021
Description: During this webinar, public health experts from CDC’s Community Guide Office and Division of Cancer Control and Prevention will present effectiveness and economic evidence from systematic reviews of intervention approaches to increase breast, cervical, and colorectal cancer screening and prevent skin cancer and discuss ways tribal communities might benefit. Presenters will discuss the role of the Community Preventive Services Task Force (CPSTF) - a nonfederal panel of unpaid experts who issue recommendations and findings based on Community Guide systematic reviews. They will highlight CPSTF findings and effectiveness and economic evidence from recent reviews and share information about CDC-funded programs that have used the findings to increase cancer screenings and share resources and weblinks attendees can use to find more information.
Speakers:
T’Ronda Flagg, MPA, MCHES
Public Health Advisor/Program Consultant, Program Services Branch, DCPC, CDC
Krista Hopkins Cole, MPH
Health Communication Specialist, Community Guide Office, CDC (Cherokee Nation Operational Solutions Contractor)
Yinan Peng, PhD, MPH
Health Scientist, Community Guide Office, CDC
Sajal K. Chattopadhyay, PhD
Economist, Community Guide Office, CDC
Learning Objectives:
- Recognize the positive evidence for CPSTF-recommended interventions to prevent skin cancer or increase breast, cervical, and colorectal cancer screening.
- Identify a CPSTF-recommended intervention to prevent skin cancer or increase breast, cervical, or colorectal cancer screening.
- Explore CDC-funded programs that have used CPSTF-recommended interventions for cancer prevention and control.
Effective Strategies to Reach Patients for Colorectal Cancer Screening During COVID-19
January 20, 2021
Presenters: Donald Haverkamp, MPH and Kevin English, DrPH
Learning Objectives
At the conclusion of this webinar, the participants will be able to:
- Apply safe and convenient colorectal screening for American Indian and Alaska Native (AI/AN) patients.
- Identify geographical differences in colorectal cancer incidence among AI/AN populations.
- Recommend appropriate testing for patients by following the draft USPSTF recommendation to begin screening average-risked persons at age 45.
